Denmark agrees to embryonic stem cell imports
This article was originally published in Clinica
Executive Summary
Danish health minister Lars Lcentkke Rasmussen last week sought to clarify Denmark's position on the importing of embryonic stem cells for research purposes. Mr Rasmussen was adamant that human eggs in Denmark could not be used to create stem cells because Danish law did not allow them to be used for any purpose other than artificial insemination. But he said that it was now possible to import existing cell lines from Sweden and the US, among other countries. "These cells cannot develop into an individual and therefore no longer have the s status of fertilised eggs," he said. The law would thus allow them to be used for research, he added.
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.